Return to content in this issue

 

Pilot experience using drug provocation testing for the study of hypersensitivity to chemotherapy and biological agents

Martí-Garrido J1,2, Vázquez-Revuelta P1,2, Lleonart-Bellfill R1,2, Molina-Mata K1,3, Muñoz-Sánchez C1,4, Madrigal-Burgaleta R1,5

1Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona
2Allergy Service, Internal Medicine Department, Bellvitge University Hospital, Barcelona
3Medical Oncology Service, Catalan Institute of Oncology, Barcelona
4Pharmacy Service, Catalan Institute of Oncology, Barcelona
5Allergy & Severe Asthma Service, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0552

Key words: Drug allergy, De-labelling, Drug challenge, Desensitization, Skin testing.

Title Type Size
doi10.1876_jiaci.0552_material-suppl.pdf pdf 267.62 Kb